-+ 0.00%
-+ 0.00%
-+ 0.00%

IONIS PARTNER GSK ANNOUNCES HIBSAGO (BEPIROVIRSEN) APPROVED IN THE U.S. FOR THE TREATMENT OF CHRONIC HEPATITIS B (CHB)

Reuters·10/21/2026 01:20:00

Please log in to view news